Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
atHeart Medical logo — Minimal footprint, more options for the future

atHeart Medical

Minimal footprint, more options for the future

Founded 2021 Switzerland Baar, Switzerland 29 employees Manufacturing, Medical Devices

General Information

Company Name atHeart Medical
Founded Year 2021
Location Switzerland Baar, Switzerland
Employees 29
Industries Manufacturing, Medical Devices
Social

BounceWatch is an independent company data service, not affiliated with atHeart Medical. To contact atHeart Medical, visit atheartmedical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About atHeart Medical

atHeart Medical is a Swiss-based manufacturing startup that is revolutionizing the treatment of atrial septal defects with its pioneering transcatheter septal occluder. Founded in 2021, the company's slogan "Minimal footprint, more options for the future" encapsulates its commitment to innovation and patient-centered care. At the core of atHeart Medical's mission is the development of a metal-free frame for its reSept ASD Occluder, setting a new standard of care in the field. The startup has embarked on the pivotal U.S. FDA approved ASCENT-ASD trial to validate the safety and efficacy of its occluder, targeting patients with clinically significant, isolated ASD. With its clinical excellence and patient-centric approach, atHeart Medical is poised to make a significant impact in the treatment of atrial septal defects. As of now, there is no public information available about the company's last investment or its investors.

Taxonomy: cardiology, transcatheter septal occluder, atrial septal defects, FDA approval, clinical trials

No funding data available for atHeart Medical yet.

atHeart Medical Alternatives & Competitors

atHeart Medical vs
InnovHeart
InnovHeart Italy

Art of Innovation, Innovation to the Heart

Series C
30 employees
Manufacturing, Medical Devices
atHeart Medical vs
Suturion
Suturion Sweden

Suturion is bringing a new gold standard for abdominal wall closure and an improved way of working.

Venture round
9 employees
Health Care, Manufacturing
atHeart Medical vs
Ablation Frontiers
Ablation Frontiers

Pioneering solutions for cardiac arrhythmias with innovative catheter systems and advanced RF techno...

Series C
Biopharma, Biotechnology

FAQ About atHeart Medical

Minimal footprint, more options for the future
atHeart Medical was founded in 2021.
atHeart Medical is headquartered in Baar, Switzerland.
atHeart Medical operates in Manufacturing and Medical Devices. Its work centres on cardiology, transcatheter septal occluder, atrial septal defects and FDA approval.
atHeart Medical has approximately 29 employees.
Top alternatives and competitors to atHeart Medical include InnovHeart, Suturion, Ablation Frontiers, Voyage Medical, Intrinsic Therapeutics, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
atHeart Medical and InnovHeart are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for atHeart Medical, https://bouncewatch.com/company/atheart-medical, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes